Diabetes groups caution doctors in prescribing Avandia

11/28/2007 | Reuters

The European Association for the Study of Diabetes and the American Diabetes Association urged greater caution in prescribing thiazolidediones, such as GlaxoSmithKline's Avandia and Takeda Pharmaceutical Co. Ltd.'s Actos, in light of recent reports linking Avandia to increased heart attack risk. Both drugs already carry strong warnings about heart failure risks.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX